Interventional, Randomized, Double-blind, Crossover, Placebo-controlled, Exploratory Study Investigating the Effects of Lu AG06466 on BOLD fMRI Signals and Sleep Parameters in Patients With PTSD
Latest Information Update: 27 Mar 2023
At a glance
- Drugs Elcubragistat (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 23 Mar 2023 Status changed from active, no longer recruiting to completed.
- 09 Feb 2023 Planned End Date changed from 14 Mar 2023 to 13 Feb 2023.
- 09 Feb 2023 Planned primary completion date changed from 7 Mar 2023 to 3 Feb 2023.